WSJ.com - U.S. Home WSJ.com - U.S. HomeBIOGEN AND ELAN PULLED their promising new multiple-sclerosis treatment Tysabri from the market following a patient's death. 11:18 p.m.

Is it possible that this could be a trend? Similar to the Vioxx
Recalls of last year, this is certainly some interesting pharmaceutical news.  ¶ 10:24 PM 3 comments

  The New York Times > Breaking News, World News & Multimedia The New York Times > Breaking News, World News & Multimedia 10 Advisers Voting for Pain Pills' Sale Have Industry Ties
By GARDINER HARRIS and ALEX BERENSON 9:39 PM ET
Ten of the advisers who endorsed continued marketing of Celebrex, Bextra and Vioxx have consulted for the drugs' makers.  ¶ 8:53 PM 0 comments

  Economist.com | Pharmaceuticals Economist.com | Pharmaceuticals Pharmaceuticals

Safety first
Feb 17th 2005
From The Economist print edition


Pain relief for America's drug regulator

Get article background  ¶ 6:29 PM 0 comments